Skip to search formSkip to main contentSkip to account menu

ibudilast

Known as: Pyrazolo(1,5-a)pyridine, 3-isobutyryl-2-isopropyl-, Ibudilastum, 3-Isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Objective:We explored the antiviral therapeutic potential of ibudilast (AV411, MN-166) and its amino analog, AV1013. Methods:We… 
2002
2002
Abstract. The effects of ibudilast, an inhibitor of phosphodiesterases (PDEs), on tension, levels of guanosine 3',5'-cyclic… 
1997
1997
Previously we have demonstrated that cells of oligodendroglial lineage express non-N-methyl-D-aspartate (NMDA) glutamate receptor… 
1996
1996
1. A microfluorometry was carried out to investigate the effect of 3‐isobutyryl‐2‐isopropylpyrazolo[1,5‐a]pyridine (ibudilast) on… 
1992
1992
Ibudilast selectively vasodilates cerebral vessels without reducing blood pressure. We investigated the effect of the drug on… 
1991
1991
She also had chronic-tension type headaches every day. For over six months, she had taken Sedes G(r) one to two grams a day… 
1990
1990
Effects of 3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine (KC-404) on cerebral circulation and metabolism were examined… 
1990
1990
The effects of 2.5 mg/kg·day ibudilast, with or without 300 mg/kg·day nicomol, or 10 mg/kg·day ibudilast on calcium and magnesium…